Track the Heyu Biological Technology Corp share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €7.9bn. The latest transaction was disclosed on 3 October 2023 (Cession). Among the most active insiders: Ang Ban Siong. Every trade is openly available.
3
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
2 ops.
Sell Volume
Fundamental score
Ranked 26,663 of 29,064 companies
20.0
score / 100
Value
21
Quality
19
FCF yld-4.7%
Earn yld-0.0%
EV/EBITDA32.8x
ROE3.0%
Gross mgn0.0%
Net mgn-0.0%
Debt/EBITDA7.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Heyu Biological Technology Corp es una empresa de biotecnología centrada en el desarrollo de soluciones de salud innovadoras. Cotiza en el mercado XNAS.